Target specificity of [18F] FETrp has also been demonstrated in preclinical prostate, lung, breast, and glioma tumor models by Xin et al. with a significantly higher tumor uptake than in low IDO1 expressing healthy tissues, and a correlation of in vitro cell binding and in vivo [18F] FETrp tumor uptake. Here, IDO1 is linked to neoplasm.